Glucosamine and Robaxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucosamine (glucosamine) and Robaxin (methocarbamol). Common drug interactions include gait disturbance among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Glucosamine and Robaxin. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Glucosamine?

Glucosamine has active ingredients of glucosamine. It is often used in joint pain. eHealthMe is studying from 15,547 Glucosamine users. Check the latest studies of Glucosamine.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.



On Jul, 15, 2026

41 people who take Glucosamine and Robaxin together, and have interactions are studied.

Glucosamine and Robaxin drug interactions.

What are the common drug interactions of Glucosamine and Robaxin, by gender? *:

female:

  1. Gait disturbance
  2. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  3. Pyrexia (fever)
  4. Renal cyst (kidney cyst)
  5. Knee arthroplasty
  6. Acquired oesophageal web (structural abnormalities in the oesophagus)
  7. Altered state of consciousness (altered state of mind)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Anogenital warts
  10. Arrhythmia (irregular heartbeat)

male:

  1. Neuropathy peripheral (surface nerve damage)
  2. Headache (pain in head)
  3. Abdominal pain upper
  4. Abscess (pus)
  5. Alcoholic liver disease
  6. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
  7. Anxiety
  8. Arrhythmia (irregular heartbeat)
  9. Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
  10. Arthropathy

What are the common drug interactions of Glucosamine and Robaxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Abscess (pus)
  3. Alcoholic liver disease
  4. Anaemia (lack of blood)
  5. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
  6. Anxiety
  7. Arrhythmia (irregular heartbeat)
  8. Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
  9. Arthropathy
  10. Atelectasis (partial or complete collapse of the lung)

30-39:

n/a

40-49:

  1. Skin discolouration (change of skin colour)

50-59:

  1. Vision blurred
  2. Abscess (pus)
  3. Acquired oesophageal web (structural abnormalities in the oesophagus)
  4. Affective disorder (mental disorder)
  5. Altered state of consciousness (altered state of mind)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anaemia (lack of blood)
  8. Ankle fracture
  9. Anogenital warts
  10. Anxiety

60+:

  1. Diarrhoea
  2. Fall
  3. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  4. Renal cyst (kidney cyst)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Spinal fracture (fracture in one of vertebrae)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  9. Abdominal pain
  10. Acquired oesophageal web (structural abnormalities in the oesophagus)

What are the existing conditions these people have? *

  1. Pain: 8 people, 19.51%
  2. High Blood Pressure: 8 people, 19.51%
  3. Metastases To Bone (cancer spreads to bone): 6 people, 14.63%
  4. Nausea (feeling of having an urge to vomit): 5 people, 12.20%
  5. Multiple Myeloma (cancer of the plasma cells): 5 people, 12.20%
  6. Diabetes: 5 people, 12.20%
  7. Stress And Anxiety: 4 people, 9.76%
  8. Prostate Cancer: 4 people, 9.76%
  9. Metastases To Bone Marrow (cancer spreads to bone marrow): 4 people, 9.76%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine and Robaxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glucosamine and Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glucosamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucosamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glucosamine and methocarbamol (the active ingredients of Glucosamine and Robaxin, respectively), and Glucosamine and Robaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: